BP
CCRN

Ballentine Partners’s Cross Country Healthcare CCRN Stock Holding History

Ballentine Partners’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,472
Closed -$191K – 1019
2025
Q3 		$191K Buy
13,472
+716
+6% +$9.46K ﹤0.01% 930
2025
Q2 		$166K Buy
+12,756
New +$175K ﹤0.01% 904

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ballentine Partners's CCRN Position: Q4 2025 in Review

Ballentine Partners sold out of Cross Country Healthcare (CCRN) in Q4 2025, closing a stake of 13,472 shares — an estimated $191K sold.

Ballentine Partners first reported a position in CCRN in Q2 2025 and held it in 2 quarters. The position peaked at $191K in Q3 2025. 147 funds tracked by Wall St. Rank hold CCRN as of Q4 2025.

  • Ballentine Partners reported no remaining Cross Country Healthcare position as of Q4 2025 after selling out during the quarter.
  • Ballentine Partners sold 13,472 Cross Country Healthcare shares in Q4 2025, an estimated $191K.
  • Ballentine Partners first reported a position in Cross Country Healthcare in Q2 2025 and held it in 2 quarters.
  • Ballentine Partners's Cross Country Healthcare position peaked at $191K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2025.

Based on Ballentine Partners's 13F filing for Q4 2025, filed 3 Feb 2026.